Havas Taps Dara Busch To Lead North America PR


(MENAFN- PRovoke) NEW YORK - With an eye on bolstering its PR offering, Havas has hired 5W's Dara Busch to lead North America PR as CEO.

Busch, most recently 5W's co-CEO, will oversee the growth and vision of the North America PR offering handled across the network, which includes Havas Formula and Havas Red US.

“I'm thrilled to be joining Havas' mission of making a meaningful difference to brands, businesses and people,” said Busch.“I look forward to working with teams across North America to uphold these client-centric values while growing the Havas Formula and Havas Red footprints.”

At 5W, Busch oversaw all agency functions as co-CEO including human resources, marketing, and business development. She also served as co-president and executive VP during her nine years with the firm.

Before joining 5W, Busch spent 16 years at Rubenstein PR, where she served as executive VP and managing director.

“It's an honor to welcome Dara into the Havas family,” said Donna Murphy, global CEO of Havas Creative Network and Havas Health Network.“As Havas' PR capabilities continue to evolve and develop, the strength of this leadership team reflects our commitment to remain at the forefront of innovation in global communications.”

James Wright, global chair Havas PR Network and global CEO Havas Red said,“We want to bring in the best talent to achieve our ambitious goals to become bigger, better and bolder.
In this next stage of our development, we want to maximize the potential for the Havas PR Network across North America and believe Dara has the ideal experience and enterprising attitude to help us achieve this.”


MENAFN04062024000219011063ID1108294914


PRovoke

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.